Published in
Wiley, Diabetes, Obesity and Metabolism, 8(20), p. 1983-1987, 2018
DOI: 10.1111/dom.13299
Links
Tools
Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study
Journal article published in 2018 by
Mikhail Kosiborod,
Kåre I. Birkeland,
Matthew A. Cavender,
Alex Z. Fu,
John P. Wilding,
Kamlesh Khunti,
Reinhard W. Holl,
Anna Norhammar 
,
Marit E. Jørgensen,
Eric T. Wittbrodt,
Marcus Thuresson,
Johan Bodegård,
Niklas Hammar,
Peter Fenici,
Cvd-Real Investigators and Study Group
,
Marit E. Jørgensen,
Eric T. Wittbrodt,
Marcus Thuresson,
Johan Bodegård,
Niklas Hammar,
Peter Fenici,
Cvd-Real Investigators and Study Group
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 